Incluye referencias bibliográficas e índice

Dedication; Foreword; Preface; Contents; Contributors; Chapter 1: Comorbidity in Rheumatic Diseases; Cardiovascular Disease in Rheumatic Disease; Epidemiology; Pathophysiology; Risk Factors; Assessment and Prediction; CV Risk Management; Infection in Rheumatic Diseases; Site-Specific Infections; Corticosteroids and Risk of Infection; Key Recommendations for Clinical Practice; Malignancy in Rheumatic Diseases; Malignancy and Systemic Lupus Erythematous; Malignancy and Rheumatoid Arthritis; Malignancy and Systemic Sclerosis; Malignancy and Inflammatory Myopathies

Effect of Comorbidity on Physical Function Comorbidity and Disease Outcomes; Medical Guidelines and Comorbidities; Management of Comorbidities; Screening; Conclusion; References; Chapter 3: Rheumatoid Arthritis; Cardiovascular Disease; Pericardial Disease; Ischaemic Heart Disease; Cardiomyopathy; Congestive Cardiac Failure; Valve Disease; Arrhythmia Including QT Effects of Drugs; Hypertension; Stroke and Peripheral Vascular Disease; Thromboembolic Disease; Respiratory Disease; Interstitial Lung Disease; Subtypes of ILD; Treatment of ILD in RA

Malignancy and Sjögren's Syndrome DMARDs and Malignancy; Rheumatic Disease and Osteoporosis; Insulin Resistance and Rheumatic Diseases; Interstitial Lung Diseases in Rheumatic Diseases; Anemia in Rheumatic Diseases; Comorbidity Pattern, Effect on Outcomes, and Recommendations for Clinical Practice; References; Chapter 2: Impact of Comorbidity; Comorbidity in Rheumatic Diseases; Prevalence; Multidimensional Impact of Comorbidity; Impact on Prescribing Medications; Financial Impact; Impact on Clinical Research; Effect of Comorbidity on Mortality

Psychosis Impact of Comorbidities in RA; Assessment and Management of Comorbidities in RA; Conclusion; References; Chapter 4: Psoriasis; Inflammatory Pathway: "The Psoriatic March" from Gene to Clinic; Psoriatic Arthritis; Background and Pathophysiology; Science-Based Medicine; Therapeutic Implications; Inflammatory Bowel Disease; Background and Pathophysiology; Science-Based Medicine; Therapeutic Implications; Obesity; Background and Pathophysiology; Science-Based Medicine; Therapeutic Implications; Diabetes Mellitus/Insulin Resistance; Background and Pathophysiology

Treatment Considerations in ILD Airways Disease; Bronchiectasis; Pleural Disease; Pulmonary Nodules; Malignancy; Cancers and Rheumatoid Arthritis; Solid Cancers; Skin Cancers; Lymphoma; Monitoring for Malignancy and Routine Care; Management of Patients Who Develop Malignancy During Treatment; Infections; Nonbiologic DMARDs and Infections; Biologics and Infections; Viral Hepatitis and Rheumatoid Arthritis; HIV and Rheumatoid Arthritis; Rheumatoid Vasculitis; Secondary MSK Disease; Osteoporosis; Osteoarthritis; Fibromyalgia; Psychological Comorbidity; Depression; Anxiety

This book explores comorbidity in patients with rheumatic diseases and details both care and treatment options in standard clinical practice.Patients with rheumatic diseases are clinically complex, and the interplay of their disease activity with associated conditions may lead to increased morbidity and mortality. Recently there have been major advances in the management of rheumatic diseases, however, without addressing the potential comorbid conditions, including cardiovascular disease; pulmonary disease; and depression; outcomes remain poor. With its 19 chapters, covering the management of major rheumatic diseases (e.g. rheumatoid arthritis, systemic lupus erythematosus , and osteoarthritis), potential comorbidities and treatment recommendations, as well as possible interactions between conditions; this book addresses the gap between textbook medicine and day to day patients' care. Authors also discuss the new hot issue of the comorbidity index, comparing the standard tools to the recently developed indices and how they can assist the rheumatologists in determining disease burden, prognosis, and comorbidity probability. This book is an ideal clinical guide and reference that enables rheumatologists, internal medicine physicians, and residents to address the full clinical expression of these rheumatic diseases with views towards prevention or early management of comorbid conditions. .